1 – 135 of 135
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy : A Swedish Nationwide Register Study
(
- Contribution to journal › Article
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
(
- Contribution to journal › Article
- 2019
-
Mark
Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article
- 2017
-
Mark
Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy
(
- Contribution to journal › Article
-
Mark
Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
(
- Contribution to journal › Article
-
Mark
Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis : Does early anti-TNF therapy bring patients back to work?
(
- Contribution to journal › Article
-
Mark
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy : A prospective observational study of patients registered in the south Swedish SSATG registry
(
- Contribution to journal › Article
-
Mark
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
(
- Contribution to journal › Article
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
- 2016
-
Mark
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
(
- Contribution to journal › Article
-
Mark
Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis : Observational Data from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal : A Prospective Observational Cohort Study from Southern Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.
(
- Contribution to journal › Article
-
Mark
Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients - baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
(
- Contribution to journal › Article
-
Mark
Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years - relation to disease activity, joint damage and comorbidity.
(
- Contribution to journal › Article
-
Mark
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
(
- Contribution to journal › Article
-
Mark
The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
(
- Contribution to journal › Article
-
Mark
Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
(
- Contribution to journal › Article
- 2014
-
Mark
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
(
- Contribution to journal › Scientific review
-
Mark
Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort
(
- Contribution to journal › Article
-
Mark
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
(
- Contribution to journal › Article
- 2013
-
Mark
Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial
(
- Contribution to journal › Article
-
Mark
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
(
- Contribution to journal › Article
-
Mark
Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs
(
- Contribution to journal › Article
-
Mark
Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures
(
- Contribution to journal › Article
- 2012
-
Mark
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis.
(
- Contribution to journal › Article
-
Mark
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment
(
- Contribution to journal › Article
-
Mark
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
(
- Contribution to journal › Article
-
Mark
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Individualized outcome measures of daily activities are sensitive tools for evaluating hand surgery in rheumatic diseases.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons.
2012) In European Journal of Neuroscience(
- Contribution to journal › Article
-
Mark
The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
(
- Contribution to journal › Article
- 2011
-
Mark
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
(
- Contribution to journal › Article
-
Mark
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Prevalence of spondyloarthritis and its subtypes in southern Sweden
(
- Contribution to journal › Article
-
Mark
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases
(
- Contribution to journal › Scientific review
-
Mark
Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
(
- Contribution to journal › Article
-
Mark
Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
(
- Contribution to journal › Article
-
Mark
Ten years with biologics: to whom do data on effectiveness and safety apply?
(
- Contribution to journal › Article
- 2010
-
Mark
Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.
(
- Contribution to journal › Article
-
Mark
Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register
(
- Contribution to journal › Article
-
Mark
Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression.
(
- Contribution to journal › Article
-
Mark
Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics.
(
- Contribution to journal › Article
-
Mark
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
(
- Contribution to journal › Article
- 2009
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
(
- Contribution to journal › Article
-
Mark
Long-term follow-up of RA patients of the Hellenic Biologics Registry: comparison of first versus second anti-TNF-alpha therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Geriatric rheumatoid arthritis patients on delayed anti-TF-alpha agents have higher disease activity and experience more often serious adverse events compared to younger adults
(
- Contribution to journal › Published meeting abstract
-
Mark
Studies of mechanisms underlying the prolonged neutrophil survival in ANCA-associated systemic vasculitis
(
- Contribution to journal › Published meeting abstract
-
Mark
Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
(
- Contribution to journal › Article
-
Mark
Measures and time points relevant for post-surgical follow-up in patients with inflammatory arthritis: a pilot study
(
- Contribution to journal › Article
-
Mark
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
(
- Contribution to journal › Article
-
Mark
Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
(
- Contribution to journal › Article
-
Mark
Six and 12 Weeks Treatment Response Predicts Continuation of Tumor Necrosis Factor Blockade in Rheumatoid Arthritis: An Observational Cohort Study from Southern Sweden.
(
- Contribution to journal › Article
-
Mark
Differences in Longitudinal Disease and Treatment Characteristics of Patients with Rheumatoid Arthritis Replying and Not Replying to a Postal Questionnaire. Experience from a Biologics Register in Southern Sweden.
(
- Contribution to journal › Article
- 2008
-
Mark
Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden
(
- Contribution to journal › Article
-
Mark
Health utilities improvement during TNF blockade in chronic arthritis occurs early in the treatment course, results from an eight year observational study in southern Sweden
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.552-552(
- Contribution to journal › Published meeting abstract
-
Mark
Why do women with early RA respond less well to MTX than men? Gender as a determinant of response in the initial phase of the Swefot trial
(
- Contribution to journal › Published meeting abstract
-
Mark
The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
(
- Contribution to journal › Published meeting abstract
-
Mark
Efficacy and tolerability of anti-TNF therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
-
Mark
Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register.
(
- Contribution to journal › Article
- 2007
-
Mark
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
(
- Contribution to journal › Article
-
Mark
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
(
- Contribution to journal › Article
-
Mark
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Behandling af reumatoid artrit med anti-tumornekrosefaktor-alpha-antistof. Individuel monitorering af biotilgaengelighed og immunogenicitet-- sekundaerpublikation
(
- Contribution to journal › Article
-
Mark
Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
(
- Contribution to journal › Article
- 2006
-
Mark
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
(
- Contribution to journal › Article
-
Mark
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
(
- Contribution to journal › Article
-
Mark
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
(
- Contribution to journal › Article
-
Mark
Swedish registers to examine drug safety and clinical issues in RA
(
- Contribution to journal › Scientific review
-
Mark
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
No increase of severe infections in RA patients treated with TNF-blockers
2005) Annual European Congress of Rheumatology, 2005 In Annals of the Rheumatic Diseases 64(Suppl. 3). p.461-462(
- Contribution to journal › Published meeting abstract
-
Mark
Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales
(
- Contribution to journal › Letter
-
Mark
Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article
-
Mark
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
(
- Contribution to journal › Article
-
Mark
Response criteria for rheumatoid arthritis in clinical practice - how useful are they?
(
- Contribution to journal › Article
-
Mark
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
(
- Contribution to journal › Article
- 2004
-
Mark
Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al
(
- Contribution to journal › Letter
-
Mark
TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept.
(
- Contribution to journal › Article
- 2002
-
Mark
Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage.
(
- Contribution to journal › Article
- 2001
-
Mark
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis
(
- Contribution to journal › Article
- 1997
-
Mark
Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction
(
- Contribution to journal › Article
- 1995
-
Mark
Hip involvement in early rheumatoid arthritis
(
- Contribution to journal › Article
- 1994
-
Mark
Prevention of joint destruction in antigen-induced arthritis
(
- Contribution to journal › Article
- 1993
-
Mark
Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)
(
- Contribution to journal › Article
-
Mark
Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
(
- Contribution to journal › Article
- 1991
-
Mark
Septic arthritis as a non-surgical complication in rheumatoid arthritis: relation to disease severity and therapy
(
- Contribution to journal › Article
- 1990
-
Mark
MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA
1990) In American Journal of Roentgenology: diagnostic imaging and related sciences 155(2). p.329-332(
- Contribution to journal › Article
-
Mark
IgM-ANCA in a patient with systemic vasculitis without pulmonary involvement
(
- Contribution to journal › Article
-
Mark
Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release
(
- Contribution to journal › Article
-
Mark
Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength
(
- Contribution to journal › Article
- 1989
-
Mark
Joint capsular stiffness in knee arthritis. Relationship to intraarticular volume, hydrostatic pressures, and extensor muscle function
(
- Contribution to journal › Article
-
Mark
Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints
(
- Contribution to journal › Article
-
Mark
Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes
(
- Contribution to journal › Article
- 1988
-
Mark
Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection
(
- Contribution to journal › Article
-
Mark
Individually adapted lightweight walking aids with moulded handles for patients with severely deforming chronic arthritis
(
- Contribution to journal › Article
-
Mark
Inhibition of ConA-induced proliferative response in human lymphocytes by podophyllotoxin and a detergent, Tween80
(
- Contribution to journal › Article
-
Mark
Measurement of oxygen and carbon dioxide partial pressures in synovial fluid after tonometry
(
- Contribution to journal › Article
-
Mark
Mononuclear cells recovered from inflammatory synovial membrane using fine-needle biopsy
(
- Contribution to journal › Article
- 1987
-
Mark
Hyaluronidase treatment of synovial fluid affects the recovery of mononuclear cells and their in vitro immunoglobulin synthesis
(
- Contribution to journal › Article
- 1984
-
Mark
Acute alveolitis and sulphasalazine in rheumatoid arthritis
(
- Contribution to journal › Article